D. Berman Lab
Daniel S. Berman, MD, is director of cardiac imaging at Cedars-Sinai and professor of medicine at UCLA. He received his medical degree at the University of California, San Francisco, and then trained in internal medicine, nuclear medicine and cardiology at the University of California, Davis. In 1977, he was recruited to Cedars-Sinai to initiate a new program in nuclear cardiology, one of the first of its kind in the U.S. Since then, his career has been devoted to clinical research in developing, validating and applying noninvasive cardiac imaging methods for the detection of coronary disease and for risk assessment of patients once the diagnosis of coronary disease has been made.
- Assessing Diagnostic Value of Non-Invasive Fractional Flow Reserve Derived From Computed Tomography (FFRCT) in Coronary Care (ADVANCE)
- 18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques
- 18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes
- Effect of EVOLocumab on coronary artery plaque Volume and composition by coronary CTA (CCTA) and microcalcification by F18-NaF PET
The D. Berman Lab collaborates with a wide range of investigators within Cedars-Sinai and institutions around the world.